Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001828185-25-000010
Filing Date
2025-02-05
Accepted
2025-02-05 16:24:18
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738790649.html 4  
1 FORM 4 wk-form4_1738790649.xml 4 4150
  Complete submission text file 0001828185-25-000010.txt   5878
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THE SCHRODINGER BUILDING HEATLEY ROAD, THE OXFORD SCIENCE PARK OXFORD X0 OX4 4GE
Business Address
Griffiths Graham (Reporting) CIK: 0001851630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40367 | Film No.: 25593643